In uterine cervix cancer, there are some IL-18 polymorphisms that have been linked to cancer progression (Tavares et al., 2016) and it has been found that a reduction of plasma IL-18 increases the risk of developing cervical cancer (Gening et al., 2014). This evidence concerns the gene IL18 and cancer.